Colin Gillespie, MD
Pulmonary Disease · Cleveland, OHNPI 1487716437
Payments from drug & device makers
Across 170 payments — averaging $350.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$18K
- Intuitive Surgical$13K
- BD$11K
- Cook Incorporated$5K
- Noah Medical Corporation$2K
- Johnson & Johnson$2K
- plus $8K from 17 others
What the payments were for
- Consulting fees$16,90034%
- Speaking & faculty fees$6,25013%
- Travel & lodging$11,22823%
- Food & beverage$8,61418%
- Education$6,00012%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 21 | $18,343 |
| Intuitive Surgical | 51 | $13,193 |
| BD | 2 | $10,804 |
| Cook Incorporated | 2 | $5,450 |
| Noah Medical Corporation | 13 | $2,305 |
| Johnson & Johnson | 20 | $1,915 |
| Pulmonx Corporation | 18 | $1,893 |
| Medical Device Business Services, Inc. | 3 | $1,611 |
| Cook Medical LLC | 11 | $1,480 |
| Bard Peripheral Vascular, Inc. | 3 | $878 |
| Coaptech, Inc. | 2 | $326 |
| Body Vision Medical Inc. | 4 | $302 |
| Covidien LP | 6 | $277 |
| Olympus America Inc. | 3 | $212 |
| Auris Health, Inc. | 2 | $210 |
| Bard Access Systems, Inc. | 1 | $114 |
| Philips North America LLC | 1 | $97 |
| Medtronic | 2 | $92 |
| ERBE USA Inc | 1 | $61 |
| Galvanize Therapeutics, Inc | 1 | $60 |
| Merck | 1 | $19 |
| ICU Medical Inc | 1 | $16 |
| Ambu Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL PULMONARY$10,644
- ACQUIRE$6,916
- Da Vinci Surgical System$6,268
- Blue Rhino$6,021
- ION$6,000
- MONARCH$2,027
- Pulmonx Endobronchial Valve EBV$1,318
- Monarch Platform$1,278
- GALAXY$891
- GENERAL - THERAPIES$402
- Cook Medical Percutaneous Tracheostomy$274
- CHARTIS CATHETER$245
- PULMONX CHARTIS TABLET CONSOLE$245
- ZEPHYR ENDOBRONCHIAL VALVE$245
- ZEPHYR DELIVERY CATHETER$245
- PUMA SYSTEM$178
- PUMA-G System$148
- superDimension$120
How this compares
$59,668 in reported general payments places this provider in the 85th percentile of 571 pulmonary disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 20 | $14,828 |
| Prednisone | 15 | $109 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Cleveland
- Kristin HighlandCleveland$3.2M
- Leslie TolleCleveland$1M
- Rodney FolzCleveland$733K
- Marie BudevCleveland$658K
- Joseph ParambilCleveland$586K
- Douglas ConradCleveland$461K
- Daniel CulverCleveland$456K
- Elliott DasenbrookCleveland$456K
- Michael MachuzakCleveland$390K
- Gustavo Heresi DavilaCleveland$357K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.